Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 9Unknown 3Terminated 3Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 27Neoplasm Metastasis 3Breast Diseases 2Vitamin D Deficiency 1Sexuality 1Recurrence 1Obesity 1Nutrition Disorders 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Hormone Receptor Positive Malignant Neoplasm of Breast 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Organoids 1Advanced Breast Cancer 1

Interventions

Fluorouracil 18Oxaliplatin 17Capecitabine 16Leucovorin 13Cisplatin 12Gemcitabine 11Drug Therapy 11Irinotecan 10Radiosurgery 9Cetuximab 9Bevacizumab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Cyclophosphamide 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × exemestane × Clear all
NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

First Hospital of China Medical University

Unknown
1,354 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT02109913 2019-10-14

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Amsterdam UMC, location VUmc

Phase NA Unknown
175 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02404051 2016-06-15

FEVEX

Consorzio Oncotech

Phase 3 Unknown
745 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡